1-3 of 3
Helena Pomares, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of Low Risk Prognostic Scoring System (LR-PSS) in Patients with Lower Risk IPSS-R Myelodysplastic Syndrome. Results from a Single Center

Montserrat Arnan Sangerman, MD PhD, Helena Pomares, MD PhD, Esther Alonso, MD, Mercedes Galiano, Maite Encuentra, Javier Grau, MD PhD, Anna Sureda, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4270.
https://doi.org/10.1182/blood-2019-127901
Published: 2019
Journal Articles

Acute Myeloid Leukemia with Myelodisplasia-Related Changes (AML-MRC) Defined Only By Morphological Findings May Not Represent a Poor Prognosis AML

Ana Pérez, MD, Olga Salamero, MD, Helena Pomares, MD PhD, Maria Julia Montoro, MD, Montserrat Arnan Sangerman, MD PhD, Laura Gallur, MD, María Laura Fox, MD, Elisa Roldan, MD, Antonieta Molero, MD, Guillermo Ortí, MD, Mayda Navarrete, MD, Esther Alonso, MD, Bárbara Tazón, PhD, M Moraima Jimenez, MD, Margarita Ortega, PhD, Adoración Blanco, PhD, Gael Roue, PhD, Pere Barba, MD PhD, Silvia Saumell, MD PhD, David Valcárcel, MD PhD, Francesc Bosch, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2612.
https://doi.org/10.1182/blood-2019-129153
Published: 2019
Journal Articles

Impact of Red Blood Cell Transfusion Burden Status in Patients with Lower-Risk Myelodysplastic Syndromes

Montserrat Arnan Sangerman, Helena Pomares, MD PhD, Esther Alonso, MD, Javier Grau, MD PhD, Mercedes Galiano, Maite Encuentra, Anna Sureda, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3013.
https://doi.org/10.1182/blood-2019-127486
Published: 2019